Online citations, reference lists, and bibliographies.
← Back to Search

Comparison Of Different Dynamic Contrast Enhanced-Magnetic Resonance Imaging Descriptors And Clinical Findings Among Breast Cancer Subtypes Determined Based On Molecular Assessment

S. Doğan, Soner Ozmen, Bahadır Öz, H. İmamoğlu, G. Kahriman, G. Zararsiz, M. Öztürk
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Background: Breast cancer is a heterogeneous disease with different molecular and histologic subtypes, clinical behaviors and prognosis. The same stage of disease and similar histopathological characteristics may show different treatment responses. Identification of breast cancer subtypes has become important for planning the targeted therapy and personalized management of patients. Objectives: To compare the clinicopathologic findings, dynamic contrast enhanced-magnetic resonance imaging (DCE-MRI) characteristics and associated MRI findings among breast cancer molecular subtypes. Patients andMethods: 267 pathologically proven invasive breast cancers in 263 patients were included. Clinicopathological findings, DCE-MRI findings and associated MRI findings were retrospectively evaluated and compared among breast cancer subtypes. Results: Invasive ductal carcinoma was the most common histological tumor type (87.6%). There were 222 (83.1%) masses and 45 (16.9%) non-mass enhancements. The molecular subtypes were luminal A in 174 (65.1%), luminal B in 45 (16.9%), human epidermal growth factor receptor 2 (HER2) positive in 24 (9%) and triple negative (TN) in 24 (9%) of the lesions. Spiculated mass margin was significantly associated with luminal A breast cancer (45.2%) and irregular shape was significantly more common in luminal A (86.3%) and luminal B lesions (95.1%) (P < 0.001). Larger mass size (P = 0.027), non-mass enhancement (P = 0.005), perilesional + prepectoral edema and skin + perilesional + prepectoral edema were significantly associated with HER2 positive breast cancer (P = 0.001). Higher histological grade, oval mass shape, circumscribed mass margin, intratumoral high/very high signal intensity on T2 weighted image (T2WI) were significantly associated with TN breast cancer (P < 0.001). Conclusion: Histological grade, size and morphological features of masses on DCE-MRI, intratumoral signal intensity on T2WI and edema pattern would be helpful to distinguish breast cancer subtypes.
This paper references
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.
L. Boudin (2016)
Can breast cancer molecular subtype help to select patients for preoperative MR imaging?
L. Grimm (2015)
Prognostic significance of Nottingham histologic grade in invasive breast carcinoma.
E. Rakha (2008)
Breast cancer molecular subtype as a predictor of the utility of preoperative MRI.
R. Ha (2015)
Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
T. Uematsu (2009)
Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
M. Schnall (2006)
Corre - lation between MR imaging - prognosis factors and molecular classification of breast cancers
C Alili (2003)
Trotti A.AJCCcancer staging manual
SB Edge (2009)
Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes
J. H. Youk (2012)
Molecular portraits of human breast tumours
C. Perou (2000)
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
M. Kyndi (2008)
Correlation between High Resolution Dynamic MR Features and Prognostic Factors in Breast Cancer
S. Lee (2008)
Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
M. Mazurowski (2014)
Molecular classification of infiltrating breast cancer: toward personalized therapy.
I. Trop (2014)
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
L. Carey (2007)
Correlation between MR imaging - prognosis factors and molecular classification of breast cancers.
C. Alili (2014)
Centrally Necrotizing Carcinomas of the Breast: A Distinct Histologic Subtype With Aggressive Clinical Behavior
R. E. Jiménez (2001)
AJCC Cancer Staging Manual
M. B. Amin (2002)
BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy.
S. Malacrida (2008)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T. Sørlie (2003)
Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI.
Fumi Kato (2016)
Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI.
B. Dogan (2010)
Breast cancer classification by proteomic technologies: current state of knowledge.
S. W. Lam (2014)
Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
K. Huber (2009)
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
R. Dent (2007)
Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors.
M. Costantini (2012)

Semantic Scholar Logo Some data provided by SemanticScholar